Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(29%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
2
29%
Ph phase_3
1
14%
Ph phase_1
1
14%
Ph early_phase_1
2
29%
Ph phase_2
1
14%

Phase Distribution

3

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
2(28.6%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (28.6%)
Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 42 (28.6%)

Trials by Status

completed343%
unknown114%
not_yet_recruiting114%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7